For the best experience on the Abcam website please upgrade to a modern browser such as Google Chrome.
synthetic peptide corresponding to residues in C-terminus of human Akt1.
Produced using Abcam’s RabMAb® technology. RabMAb® technology is covered by the following U.S. Patents, No. 5,675,063 and/or 7,429,487.
A trial size is available to purchase for this antibody.
Alternative versions available:
Our Abpromise guarantee covers the use of ab32505 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
|ICC/IF||1/100 - 1/250.|
|WB||1/5000 - 1/10000. Detects a band of approximately 59 kDa (predicted molecular weight: 56 kDa).Can be blocked with AKT1 peptide (ab205611).|
|Flow Cyt||1/20. ab172730-Rabbit monoclonal IgG, is suitable for use as an isotype control with this antibody.|
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"